Pressure Biosciences Probability of Future OTC Stock Price Finishing Under 0.70
| PBIODelisted Stock | USD 0.49 0.00 0.00% |
Pressure |
Pressure Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pressure Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pressure Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pressure Biosciences is not yet fully synchronised with the market data | |
| Pressure Biosciences has some characteristics of a very speculative penny stock | |
| Pressure Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Pressure Biosciences currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 2.04, implying the company greatly relies on financing operations through barrowing. Pressure Biosciences has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Pressure Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Pressure Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pressure Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pressure to invest in growth at high rates of return. When we think about Pressure Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2 M. Net Loss for the year was (20.15 M) with profit before overhead, payroll, taxes, and interest of 1.06 M. | |
| Pressure Biosciences currently holds about 121.57 K in cash with (4.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Pressure Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pressure OTC Stock often depends not only on the future outlook of the current and potential Pressure Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pressure Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.1 M |
Pressure Biosciences Technical Analysis
Pressure Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Pressure OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pressure Biosciences. In general, you should focus on analyzing Pressure OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Pressure Biosciences Predictive Forecast Models
Pressure Biosciences' time-series forecasting models is one of many Pressure Biosciences' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pressure Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Pressure Biosciences
Checking the ongoing alerts about Pressure Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pressure Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pressure Biosciences is not yet fully synchronised with the market data | |
| Pressure Biosciences has some characteristics of a very speculative penny stock | |
| Pressure Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Pressure Biosciences currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 2.04, implying the company greatly relies on financing operations through barrowing. Pressure Biosciences has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Pressure Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Pressure Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pressure Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pressure to invest in growth at high rates of return. When we think about Pressure Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2 M. Net Loss for the year was (20.15 M) with profit before overhead, payroll, taxes, and interest of 1.06 M. | |
| Pressure Biosciences currently holds about 121.57 K in cash with (4.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |